Last reviewed · How we verify

NCT05960981

Effects of Parent-Mediated Intervention on Restricted and Repetitive Behaviors in Children With ASD

Completed NA Last updated 27 July 2023
What this trial tests

NA trial testing Online-delivered Group-based Parent Mediated Intervention for Young Children with ASD in Autism Spectrum Disorder in 65 participants. Completed in 18 December 2022.

Timeline
12 March 2022
Primary endpoint
18 December 2022
18 December 2022

Quick facts

Lead sponsorSabri Hergüner
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment65
Start date12 March 2022
Primary completion18 December 2022
Estimated completion18 December 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Sabri Hergüner

Who can join

Adults 24 Months to 72 Months, any sex, with Autism Spectrum Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Our primary aim in the study is to investigate the effect of an online group-based 8-week parent-mediated intervention program targeting social communication on restrictive repetitive behaviors. Our second aim is to investigate the factors affecting the change in restrictive repetitive behavior. Our hypotheses are that after completing the 8-week online group-based parent-mediated intervention program, the participants' social interaction skills will increase, their restrictive repetitive behaviors will decrease, and their emotion regulation problems will decrease.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Autism Spectrum Disorder

Currently open trials in the same condition.

Other Sabri Hergüner trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05960981.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing